Reevaluating Chronic Disease Management

This chapter examines the alarming rise of chronic conditions like Alzheimer's and diabetes, emphasizing the need for a shift in health policy towards lifestyle biomarkers rather than pharmaceuticals. It also addresses the interconnected nature of these diseases, highlighting flaws in current research and the impact of economic incentives on healthcare ethics.